Skip to content

DR. DEWACHTER P. MBV

Active
Private limited companyfounded 2017active for 8 yearsNapoleonkaai 7, 2000 Antwerpen, BelgiumKBO/BCE: BE 0686.756.535
Summary

DR. DEWACHTER P. MBV has been active since 2017 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €86,263 and a net result of €180,746. Equity has been stable since 2018 (±1.8% per year). Its solvency ranks better than 29% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 22-12-2017 Normal situation
Activity
Specialist medical practice NACE 86220and 1 other
Establishment unit
2.271.759.794 2000 Antwerpen, since 22-12-2017
Financial year end
31 December
Peppol
Reachable since 24-11-2023

Board and ownership

Board

Financial position

93 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€244,902
▲ 25.0%
Turnover
≈ €460,000
estimated
Profit
€180,746
▲ 34.4%
Equity
€86,263
▼ 40.3%
Total assets
€247,348
▲ 24.7%
Filed on 31-07-2026, on time
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.46, cash €92,103Size: total assets €247,348Figures for financial year 2025 (filed on 01-08-2026)Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 41% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 60-38
equity 34.9% of total assets
Liquidity 62-12
short-term debt 65.1% · cash 37.2%
Profitability 100=
return on assets 73.1%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: 0.1%▲ +0.1 percentage points vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025highest value 07-2025: < 0.1%▼ -0.1 percentage points vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026lowest value 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €8,000 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.46 (3.46 in 2024), below the usual 1.5. Short-term debt is 65.1% and cash 37.2% of total assets. 65.1% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 29% of them on solvency, 40% on liquidity, 80% on profitability and 15% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 1.46, cash €92,103
NBB · annual accounts
lowers risk · Size: total assets €247,348
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 01-08-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-07-2026, 0 days ahead of the deadline.
NBB · 9 filings
Deviation from the deadline
2025
on the day
2024
on the day
2023
54 days early
2022
26 days early
2021
61 days late
2020
184 days late
2019
122 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 41 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 31 July (4 of the last 5 accounts filed within 53 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher net result than 85% of companies in human healthsector median €60,139 · 20,665 companies €180,746 View
  • Positive: 8 profitable years in a rowprofit 2025: €180,746 8 years View
  • Caution: Equity fell in 2025from €144,518 to €86,263 ▼ 40.3% View
  • Positive: Filed on time since financial year 2022accounts within the deadline every year 4 years View

Recent changes

  1. · Gazette deed Registered office moved to AntwerpenAppointment: DEWACHTER Patrick (director)
  2. · Gazette deed Incorporation
All 18 events

Comparable companies

These companies have the same main activity as DR. DEWACHTER P. MBV: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €218,000 and €253,000, founded between 2017 and 2018.

CompanyTotal assetsGross margin
DR. DEWACHTER P. MBV Antwerpen€247,348€244,902
Mamophi Herentals€243,704€250,279
HEMATO KAPELLEN Kapellen€253,183€274,646
DOKTER SOFIE TORFS - GYNAECOLOGIE Herentals€246,970€272,000
D. PEETERS PATHOLOGIE Lint€230,221€273,999
DR. O. MEEUS Duffel€218,327€267,624
DR. PHILIPPE BORREMAN Kortenaken€240,745€234,956
Full comparison

Key facts about DR. DEWACHTER P. MBV

What is the company number of DR. DEWACHTER P. MBV?
The company number of DR. DEWACHTER P. MBV is 0686.756.535. The VAT number is the same number with BE in front: BE 0686.756.535.
Where is DR. DEWACHTER P. MBV based?
The registered office is at Napoleonkaai 7, 2000 Antwerpen.Company details
What does DR. DEWACHTER P. MBV do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR. DEWACHTER P. MBV?
The legal form of DR. DEWACHTER P. MBV is Private limited company (BV).
When was DR. DEWACHTER P. MBV founded?
DR. DEWACHTER P. MBV was founded on 22-12-2017.
Is DR. DEWACHTER P. MBV still active?
Yes, DR. DEWACHTER P. MBV is an active enterprise in the KBO register.
What is the turnover of DR. DEWACHTER P. MBV?
The turnover in financial year 2025 is ≈ €460,000. This figure is estimated from the gross margin of €244,902 and 43 comparable companies (NACE 86220). It probably lies between €390,000 and €610,000.Financials
Is DR. DEWACHTER P. MBV profitable?
In financial year 2025, DR. DEWACHTER P. MBV made a profit of €180,746.
Where can I find the annual accounts of DR. DEWACHTER P. MBV?
DR. DEWACHTER P. MBV filed 9 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. DEWACHTER P. MBV due?
DR. DEWACHTER P. MBV must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.